CM
CM Management Portfolio holdings
AUM
$110M
This Quarter Return
+5.23%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$110M
AUM Growth
+$110M
(+10%)
Cap. Flow
-$12.5M
Cap. Flow
% of AUM
-11.42%
Top 10 Holdings %
Top 10 Hldgs %
39.83%
Holding
76
New
22
Increased
18
Reduced
15
Closed
9
Top Buys
| 1 |
MarineMax
HZO
|
$2.01M |
| 2 |
IQVIA
IQV
|
$1.89M |
| 3 |
Winnebago Industries
WGO
|
$1.16M |
| 4 |
Warner Bros
WBD
|
$1.15M |
| 5 |
Pfizer
PFE
|
$1.09M |
Top Sells
| 1 |
Nektar Therapeutics
NKTR
|
$19.5M |
| 2 |
Freeport-McMoran
FCX
|
$2.65M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$2.48M |
| 4 |
Cytokinetics
CYTK
|
$1.61M |
| 5 |
Cohu
COHU
|
$1.54M |
Sector Composition
| 1 | Healthcare | 31.09% |
| 2 | Technology | 10.92% |
| 3 | Materials | 10.24% |
| 4 | Financials | 10.01% |
| 5 | Industrials | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
ScottsMiracle-Gro
SMG
$3.53B
| $660K | 0.6% |
+10,000
| New | +$660K |
|
52
Lantern Pharma
LTRN
$44.1M
| $632K | 0.58% |
200,000
| – | – |
|
53
Euronet Worldwide
EEFT
$3.82B
| $608K | 0.55% |
+6,000
| New | +$608K |
|
54
Newell Brands
NWL
$2.48B
| $540K | 0.49% |
100,000
+50,000
| +100% | +$270K |
|
|
B
55
Barrick Mining Corporation
B
$45.4B
| $521K | 0.47% |
+25,000
| New | +$521K |
|
56
Curis
CRIS
$20.9M
| $510K | 0.46% |
220,000
-20,000
| -8% | -$46.4K |
|
57
Aviat Networks
AVNW
$292M
| $481K | 0.44% |
+20,000
| New | +$481K |
|
58
PACCAR
PCAR
$52.5B
| $475K | 0.43% |
+5,000
| New | +$475K |
|
59
Assertio
ASRT
$80.4M
| $464K | 0.42% |
724,382
+249,382
| +53% | +$160K |
|
60
BILL Holdings
BILL
$4.72B
| $463K | 0.42% |
+10,000
| New | +$463K |
|
61
SS&C Technologies
SSNC
$21.7B
| $414K | 0.38% |
+5,000
| New | +$414K |
|
|
62
Cohu
COHU
$929M
| $385K | 0.35% |
20,000
-80,000
| -80% | -$1.54M |
|
63
Helen of Troy
HELE
$564M
| $284K | 0.26% |
+10,000
| New | +$284K |
|
64
BioCardia
BCDA
$11.5M
| $254K | 0.23% |
130,000
+55,000
| +73% | +$107K |
|
65
Femasys
FEMY
$11.6M
| $217K | 0.2% |
225,000
-200,000
| -47% | -$193K |
|
66
Elicio Therapeutics
ELTX
$172M
| $193K | 0.18% |
25,000
-30,000
| -55% | -$232K |
|
67
Cognition Therapeutics
CGTX
$179M
| $77.5K | 0.07% |
250,000
-150,000
| -38% | -$46.5K |
|
68
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – |
-75,000
| Closed | -$1.25M |
|
69
Battalion Oil
BATL
$19.4M
| – | – |
-135,000
| Closed | -$176K |
|
|
70
Cytokinetics
CYTK
$4.23B
| – | – |
-40,000
| Closed | -$1.61M |
|
71
Dell
DELL
$82.6B
| – | – |
-5,000
| Closed | -$456K |
|
|
72
Freeport-McMoran
FCX
$63.7B
| – | – |
-70,000
| Closed | -$2.65M |
|
73
Hasbro
HAS
$11.4B
| – | – |
-10,000
| Closed | -$615K |
|
74
Herc Holdings
HRI
$4.35B
| – | – |
-5,000
| Closed | -$671K |
|
|
75
Jazz Pharmaceuticals
JAZZ
$7.75B
| – | – |
-20,000
| Closed | -$2.48M |
|